fluorodopa f 18 has been researched along with Adenomatosis, Familial Endocrine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giovanella, L; July, M; Santhanam, P; Treglia, G | 1 |
Adzick, NS; Alavi, A; Becker, S; Divgi, C; Ernst, LM; Freifelder, R; Hardy, OT; Hernandez-Pampaloni, M; MacMullen, C; Saffer, JR; Scheuermann, JS; Stanley, CA; Zhuang, H | 1 |
1 review(s) available for fluorodopa f 18 and Adenomatosis, Familial Endocrine
Article | Year |
---|---|
Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes.
Topics: 5-Hydroxytryptophan; Biomarkers, Tumor; Dihydroxyphenylalanine; Ephedrine; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Methionine; Multiple Endocrine Neoplasia; Mutation; Phenotype; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin | 2018 |
1 other study(ies) available for fluorodopa f 18 and Adenomatosis, Familial Endocrine
Article | Year |
---|---|
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism.
Topics: Biopsy; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Islets of Langerhans; Kidney; Multiple Endocrine Neoplasia; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sample Size | 2007 |